Thursday, September 18, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Israeli co Nectin Therapeutics raises $25m

by Globes correspondent
November 30, 2022
in Business
Reading Time: 2 mins read
A A
0
Home Business
Share on FacebookShare on Twitter

Israeli biotechnology company Nectin Therapeutics has announced that it has completed a $25 million Series A financing round led by IBF and Peregrine Ventures, with participation from aMoon Fund and other existing investors.

Jerusalem-based Nectin is developing novel targeted immunotherapies to address resistance to approved immuno-oncology treatments. The company also announced today dosing of the first patient in its Phase I clinical trial of NTX1088, the company’s first-in-class PVR (CD155) blocker, in cancer patients with locally advanced and metastatic solid tumors. The trial is being conducted at The University of Texas MD Anderson Cancer Center (MD Anderson) with an investment from the Cancer Focus Fund, LP. The trial will include up to 90 patients treated with NTX1088 as a monotherapy and in combination with a PD-1 blocker.

The Series A funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company’s pipeline of targeted immunotherapies and Antibody Drug Conjugates (ADCs).

NTX1088 is a first-in-class high-affinity monoclonal antibody directed against PVR, a transmembrane protein expressed on cancer cells and associated with resistance to PD-1 and PD-L1 immune checkpoint inhibitors.

Nectin cofounder and CSO Dr. Pini Tsukerman said, “PVR blockade by NTX1088, with its first-in-class differentiated mechanism of action, has demonstrated compelling preclinical anti-tumor activity both as a monotherapy and in combination with other cancer immunotherapies. Importantly, NTX1088 has potent activity in ICI refractive models where TIGIT or PD-1 blockade has failed to show a benefit.”

Nectin CEO Fabian Tenenbaum added, “Nectin has developed a highly innovative pipeline that has the potential to fundamentally overcome the limitations of existing IO therapies, delivering new treatment options for patients suffering from difficult-to-treat cancers, and we look forward to the results of the Phase 1 clinical trial of NTX1088.”

Published by Globes, Israel business news – en.globes.co.il – on November 30, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.




Source link

Tags: 25MIsraeliNectinraisesTherapeutics
Previous Post

New Fortress: Valuation May Get Reset Shortly (NASDAQ:NFE)

Next Post

Recession Playbook – The Reformed Broker

Related Posts

Tariffs Pushing Up Prices, But Wider Impact Unclear, Says Powell After Fed Rate Cut

Tariffs Pushing Up Prices, But Wider Impact Unclear, Says Powell After Fed Rate Cut

by NDTV Profit Desk
September 17, 2025
0

The tariffs imposed by US President Donald Trump on most buying and selling companions are pushing up the costs, however...

With the US and UK pouring billions into AI, India is pressed to step up its game

With the US and UK pouring billions into AI, India is pressed to step up its game

by Euro Times
September 17, 2025
0

International AI investments are accelerating at an unprecedented tempo. Microsoft on Tuesday introduced a $30 billion dedication to increase its...

Travel booking co Navan to file for Wall Street IPO

Travel booking co Navan to file for Wall Street IPO

by Assaf Gilead
September 18, 2025
0

US-based journey reserving firm Navan will file a Type S-1 to the US Securities and Trade Fee for an...

Vedanta shares drop 4% as govt reportedly doubles down against demerger plan

Vedanta shares drop 4% as govt reportedly doubles down against demerger plan

by Shivendra Kumar
September 17, 2025
0

Metallic main Vedanta's shares fell practically 4% on Wednesday to hit the day's low of Rs 471 after its demerger...

From RailTel, Coal India, MCX, BEL to Maharashtra Seamless, stocks to track on September 17

From RailTel, Coal India, MCX, BEL to Maharashtra Seamless, stocks to track on September 17

by zee business
September 17, 2025
0

Shares to Monitor on September 17: Home fairness benchmarks registered sharp positive factors on Tuesday amid positive factors in monetary...

Trump Extends Deadline To Secure TikTok Deal Until December 16

Trump Extends Deadline To Secure TikTok Deal Until December 16

by Bloomberg News
September 16, 2025
0

President Donald Trump once more prolonged the deadline for TikTok’s Chinese language mother or father ByteDance Ltd. to divest the...

Next Post
Recession Playbook – The Reformed Broker

Recession Playbook - The Reformed Broker

How to Read Your Property Insurance Policy

How to Read Your Property Insurance Policy

Indian celebrities with UAE Golden Visa: Full list and why they’re choosing the Emirates | World News

Indian celebrities with UAE Golden Visa: Full list and why they’re choosing the Emirates | World News

September 17, 2025
Tariffs Pushing Up Prices, But Wider Impact Unclear, Says Powell After Fed Rate Cut

Tariffs Pushing Up Prices, But Wider Impact Unclear, Says Powell After Fed Rate Cut

September 17, 2025
House committee asks Discord, Valve, Twitch and Reddit to testify on online radicalization

House committee asks Discord, Valve, Twitch and Reddit to testify on online radicalization

September 17, 2025
Here’s what that means for you

Here’s what that means for you

September 17, 2025
UN armored vehicle crashes in Central African Republic, killing 5 police officers

UN armored vehicle crashes in Central African Republic, killing 5 police officers

September 17, 2025
9 Balance Exercises That Can Boost Strength and Prevent Falls

9 Balance Exercises That Can Boost Strength and Prevent Falls

September 17, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Indian celebrities with UAE Golden Visa: Full list and why they’re choosing the Emirates | World News

Tariffs Pushing Up Prices, But Wider Impact Unclear, Says Powell After Fed Rate Cut

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In